Singaporean biotech startup TurtleTree secures pre-seed from Saudi entrepreneur Prince Khaled bin Alwaleed
by e27 2020-01-21
Share on
source: e27

KBW Ventures, the VC firm owned by Saudi entrepreneur and investor HRH Prince Khaled bin Alwaleed bin Talal, who’s also a prince of the House of Saud, and son of businessman Al-Waleed bin Talal, announces the pre-seed investment into Singapore-based biotech company TurtleTree.

Entrepreneur reported that the pre-seed round is led by US-Hong Kong venture capital fund specialising in alternative protein investments, Lever VC, and includes KBW Ventures and Silicon Valley-based K2 Global.

TurtleTree uses technology to create real milk from animal cells, with no animal required.

The company is co-founded by CEO Fengru Lin, Chief Scientist Officer Rabail Toor, and Chief Strategist Max Rye. Its proprietary technology allows the use of mammary cells to produce full milk in clean food production facilities.